Accelerating Bispecific Antibody Discovery: From Antigens to Lead Panels in Just Four Months
Rapid Bispecific Discovery and the B-Body Bispecific Platform de-risk and accelerate antibody therapeutics.
Related Articles
Canadian forests are more conducive to high-severity fires in recent decades
Canada has experienced more-intense and longer fire seasons with more-frequent uncontrollable wildfires over the past decades. However, the effect of these changes remains unknown. This…
Better care urged for animal remains tied to Indigenous peoples
New recommendations stress tracing and respecting links between communities and animal bones, pelts and other remains
On the trail with a truffle-hunting dog, and why we should save elderly plants and animals
On this week’s show: How truffle dogs can contribute to conservation of underground fungi, and the importance of age diversity
Farmers are abandoning land worldwide. What should happen to it?
Ecologists differ on whether to steer recovery or let nature take its course
KARR-seq reveals cellular higher-order RNA structures and RNA–RNA interactions
Nature Biotechnology – RNA interactions and structures are determined with a chemical labeling and crosslinking method.
A global analysis of dairy consumption and incident cardiovascular disease
Nature Communications – The role of dairy products in cardiovascular disease (CVD) prevention is debated. Here, the authors show that dairy consumption is associated with…
Korea University Anam Hospital to pilot LLM next year
Data of around six million patients are currently being vectorised as part of this development, according to CIO and professor Sang-Heon Lee.
T Cells in People Already Offer Some Protection Against Bird Flu
Researchers are prepared to analyze immune cells from human samples should H5N1 begin spreading between people.
NeuroFlow inks deal with Intermountain Health for behavioral health
Intermountain Health’s behavioral health risk model will be integrated into NeuroFlow’s platform.
